Article Detail

Home > Article Detail
  • P-ISSN 1010-0695
  • E-ISSN 2288-3339

An Approach of Traditional Korean Medicine to Cancer, the Leading Cause of Disease Burden

Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2008, v.29 no.4, pp.47-54

  • Downloaded
  • Viewed

Abstract

Objective: The purpose of this study was to investigate the disease burden of cancer, to investigate how many cancer patients use CAM (complementary and alternative medicine) therapies with or without conventional medicine, to know reasons for use of cancer CAM therapies, and finally to discuss viewpoints on treating cancer with traditional Korean medicine (TKM). Method: In order to know the disease burden of cancer, the prevalence and mortality of cancer patients of Korean, American, and WHO reports were investigated, and the usage of cancer CAM therapies was investigated in several reports. The viewpoints about cancer treatment with TKM were suggested with the characteristics of TKM. Results: One hundred thousand Korean people were diagnosed [in time period] as new cancer patients, and cancer patients are gradually increasing every year. Cancer is a leading cause of deaths in Korea and worldwide. From 21% to 63% of Korean cancer patients, 80% of American cancer patients, and 35.9% of European cancer patients used CAM therapies, and the most common therapy was an herbal therapy. Conclusions: TKM has been used to treat cancer since initial use of acupuncture and herbs with basic viewpoints on human health and disease. First, TKM regards occurrence of cancer as an environmental problem of the whole human being. Second, the pathologic concept centered on antipathogenic Qi (Zheong Qi) can reinforce the functioning of the patient’s own natural vitality to overcome cancer. Third, TKM deals with cancer patients through mind, body, and spirit based on the monoism of mind and body.

keywords
Cancer, traditional Korean medicine (TKM), disease burden, complementary and alternative medicine, incidence, mortality, Korean, Cancer, traditional Korean medicine (TKM), disease burden, complementary and alternative medicine, incidence, mortality, Korean


Reference

1

1. What is cancer ? National cancer institute. Available at (http://www.cancer.gov/cancertopics /what-is-cancer).

2

2. 최승훈. 동의종양학. 서울. 행림출판. 1995:13.

3

3. 조종관. 한방임상종양학. 대전. 주민출판사. 2001 :3-18.

4

4. WHO (February 2006). Cancer. World health organization. Retrieved on 2007-06-25.

5

5. 2006년 사망 및 사망원인통계결과. 한국통계청. 2006. Available at (http://www.kosis.kr/search/ totalSearch2.jsp?detailSearch=block&query=2006년%20사망원인통계)

6

6. Annual report of the Korea central cancer registry in 2002. Korea central cancer registry / Ministry of health and welfare republic of Korea. 서울. 2003.

7

7. Cancer facts and figures 2007. American cancer society. Available at (http://www.cancer.org/downloads/STT/caff2007PWSecured.pdf)

8

8. Murray CJ, Lopez AD, eds. The global burden of disease : a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge :harvard university press, 1996.

9

9. Hyder AA, Rotllant G, Morrow RH. Measuring the burden of disease : healthy life years. Am J Public Health. 1998;88(2):196-202.

10

10. 최용준, 윤석준, 김창업외. 건강생활년을 이용한 우리나라 주요 암 질환의 질병 부담 측정. 예방의학회지. 2001;34(4):372-378. (636)

11

11. 유화승, 이용연, 서양훈외. 서구 대체의학의 암치료에 관한 연구. 대한한방종양학회지. 2000;6(1): 125-148.

12

12. 장동민. 암환자의 의료 이용행태에 관한 연구. 대한보건협회학술지. 1998;24(2):106-117.

13

13 최윤정, 정해원, 최수용. 일부 병원에 내원한 암환자들의 대체의학 사용에 관한 연구. 대한보건협회학술지. 1998;24(1):167-181.

14

14. Kim MJ, Lee SD, Kim DR et al. Use of compl- ementary and alternative medicine among Korean cancer patients. The Korean Journal of Internal Medicine. 2004;19:250-256.

15

15. Kim SG, Park EC, Park JH et al. Initiation and discontinuation of complementary therapy among cancer patients. Journal of Clinical Oncology. 2007;25(33):5267-5274.

16

16. Cassileth BR, Deng G. Complementary and alternative therapies for cancer. The Oncologist. 2004;9:80-89.

17

17. Rosenthal DS. Dean-Clower E. Integrative med- icine in hamatology/oncology:benefits, ethical, considerations, and controversies. Hematology. 2005;491-497.

18

18. Molassiotis A, Fernadez-Ortega P, Pud D et al. Use in complementary and alternative medicine in cancer patients ; a European survey. Annals of Oncology. 2005;16:655-663.

19

19. Hann D, Baker F, Denniston M, et al. Long-term breast cancer survivors use of complementary therapies: perceived impact on recovery and prevention of recurrence. Integrative Cancer Therapy. 2005;4:14-20.

20

20. Hann D, Baker F, Roberts CS et al. Use of complementary therapies among breast and prostate cancer patients during treatment : a mul- tiple study. Integrative Cancer Therapy. 2005;4: 294-300.

21

21. 국민건강보험공단, 건강보험심사평가원. 2006 건강보험통계연보 (ISSN1738-8945). 2007(12). 서울. 삼원인쇄. 316-323.

22

22. Nahin RL. Identifying and pursuing research priorities at the national center for complementary and alternative medicine. The Journal of the Federation of American Societies for Experim- ental Biology. 2005;19:1209-1215.

23

23. Wetzel MS, Eisenberg DM, Kaptchuk TJ. Courses involving complementary and alternative medicine at US medical schools. Journal of the American Medical Association. 1998;280(9):784 -787.

24

24. Robotin MC, Penman AG. Integrating comple- mentary therapies into mainstream cancer care; which way forward ? The Medical Journal of Australia. 2006;185(7):377-379.

  • Downloaded
  • Viewed
  • 0KCI Citations
  • 0WOS Citations

Other articles from this issue

Recommanded Articles

상단으로 이동

Journal of Korean Medicine